|
|
|
|
FDA inspections of domestic food facilities. : United States.
|
2010
|
1
|
|
|
FDA is issuing more postmarketing requirements, but challenges with oversight persist. : United States.
|
2016
|
1
|
|
|
FDA may have opportunities to expand its use of reported health problems to oversee products : United States.
|
2013
|
1
|
|
|
FDA medical products reporting program
|
1997
|
1
|
|
|
FDA narcotic treatment programs directory (Online) / United States. Food and Drug Administration. (DLC) 2010230203 (OCoLC)53441765
|
2000
|
1
|
|
|
FDA needs to better leverage resources, improve oversight, and effectively use available data to hel : United States.
|
2008
|
1
|
|
|
FDA needs to do more to ensure that drug labels contain up-to-date information : United States.
|
2012
|
1
|
|
|
FDA needs to enhance its oversight of drugs approved on the basis of surrogate endpoints : United States.
|
2009
|
1
|
|
|
FDA needs to establish key plans and processes for guiding systems modernization efforts : United States.
|
2009
|
1
|
|
|
FDA needs to fully implement key management practices to lessen modernization risks : United States.
|
2012
|
1
|
|
|
FDA needs to reassess its approach to protecting consumers from false or misleading claims : United States.
|
2011
|
1
|
|
|
FDA needs to reassess its approach to reducing an illness caused by eating raw oysters : United States.
|
2011
|
1
|
|
|
FDA needs to set time frames for its review process : United States.
|
2013
|
1
|
|
|
FDA oversight has increased, and available information does not indicate that use presents an elevat : United States.
|
2008
|
1
|
|
|
FDA oversight of clinical investigators.
|
|
2
|
|
|
FDA oversight of direct-to-consumer advertising has limitations : United States.
|
2002
|
1
|
|
|
FDA penalty adjustments : Rezendes, Victor S.
|
2002
|
1
|
|
|
FDA postmarket risk system : United States.
|
2009
|
1
|
|
|
The FDA prescription drug file. : United States.
|
1991
|
1
|
|
|
FDA program changes and better collaboration among key federal agencies could improve detection and : United States.
|
2009
|
1
|
|
|
FDA protetects the public health [electronic resource] : ranks high in public trust.
|
2002
|
1
|
|
|
FDA refusals of imported food products by country and category, 2005-2013 : Bovay, John,
|
2016
|
1
|
|
|
FDA regulation of blood and blood products : recent draft guidance on donor eligibility : Sussman, Jared S.,
|
2023
|
1
|
|
|
FDA regulation of cannabidiol (CBD) consumer products : Bodie, Agata,
|
2019
|
1
|
|
|
FDA regulation of cannabidiol (CBD) consumer products : overview and considerations for Congress : Bodie, Agata,
|
2020
|
1
|
|
|
FDA regulation of laboratory-developed tests (LDTs) : Sarata, Amanda K.,
|
2020
|
1
|
|
|
FDA regulation of tobacco products [electronic resource]
|
2009
|
1
|
|
|
fda regulation of tobacco would unfairly benefit the largest tobacco companies
|
2009
|
1
|
|
|
fda regulation would protect tobacco companies from the threat of litigation
|
2009
|
1
|
|
|
FDA response to heparin contamination : United States.
|
2010
|
1
|
|
|
FDA review of vaccine labeling requirements for warnings, use instructions, and precautionary inform
|
2004
|
1
|
|
|
FDA review time : United States.
|
1995
|
1
|
|
|
FDA reviews of new tobacco product submissions : United States.
|
2013
|
1
|
|
|
FDA safety and consumer protections are often less stringent than comparable EPA protections for tap : United States.
|
2009
|
1
|
|
|
FDA safety information and adverse event reporting program
|
1997
|
1
|
|
|
FDA should expand Its consideration of information security for certain types of devices : United States.
|
2012
|
1
|
|
|
fda should not allow pharmacists to dispense behind the counter drugs
|
2009
|
1
|
|
|
FDA should strengthen Its oversight of food ingredients determined to be Generally Recognized as Saf : United States.
|
2010
|
1
|
|
|
FDA should take additional steps to improve its Foreign Inspection Program : United States.
|
2022
|
1
|
|
|
FDA should take further actions to improve oversight and consumer understanding : United States.
|
2009
|
1
|
|
|
fda software validation regulations and why you should validate software anyway : Vogel, David A.,
|
2011
|
1
|
|
|
FDA taking closer look at 'antibacterial' soap [electronic resource].
|
2013
|
1
|
|
|
FDA to consider whether and how to lower permissible nicotine levels in cigarettes : Barry, Matthew B.,
|
2018
|
1
|
|
|
fda tobacco bill is a misguided piece of legislation
|
2009
|
1
|
|
|
fda today 2009 : Vogel, David A.,
|
2011
|
1
|
|
|
FDA user fees 2012 (2013) : United States.
|
2013
|
1
|
|
|
FDA user fees 2012 [electronic resource] : how innovation helps patients and jobs : hearing before t : United States.
|
2013
|
1
|
|
|
FDA user fees 2012 [electronic resource] : issues related to accelerated approval, medical gas, anti : United States.
|
2013
|
1
|
|
|
FDA user fees [electronic resource] : advancing public health : hearing of the Committee on Health, : United States.
|
2014
|
1
|
|
|
FDA [videorecording] : a history
|
2010
|
1
|
 Add Marked to Bag
Add All On Page
|
